New perspectives in lung cancer.5. New drugs in lung cancer.
作者信息
Talbot D C, Smith I E
机构信息
Lung Unit, Royal Marsden Hospital, Sutton, Surrey.
出版信息
Thorax. 1992 Mar;47(3):188-94. doi: 10.1136/thx.47.3.188.
Abstract
摘要
相似文献
1
New perspectives in lung cancer.5. New drugs in lung cancer.
Thorax. 1992 Mar;47(3):188-94. doi: 10.1136/thx.47.3.188.
2
Evaluation of new drugs in untreated patients with small-cell lung cancer: its time has come.
J Clin Oncol. 1990 Mar;8(3):374-7. doi: 10.1200/JCO.1990.8.3.374.
3
Drugs in the Pipeline: Non-Small-Cell Lung Cancer.
Oncology (Williston Park). 2019 Sep 20;33(9):684948.
4
[Cancer of the lung. New perspectives in medical treatment].
Arch Monaldi Mal Torace. 1989 Jul-Dec;44(4-6):781-90.
5
Phase II study of carbetimer in non-small cell lung cancer.
Invest New Drugs. 1990 Nov;8(4):385-6. doi: 10.1007/BF00198596.
6
Vinorelbine treatment IND program announced.
Am J Hosp Pharm. 1994 Sep 1;51(17):2087.
7
Lung cancer. Chemotherapy.
Am J Nurs. 1987 Nov;87(11):1438-9, 1440-1.
8
[Current outcomes and future directions in the chemotherapy of lung cancer].
Fukuoka Igaku Zasshi. 1993 Sep;84(9):389-94.
9
Chemotherapy in lung cancer.
Postgrad Med J. 1989 May;65(763):291-8. doi: 10.1136/pgmj.65.763.291.
10
[Effects, possibilities and limits. Cytostatic therapy of small cell and non-small cell lung cancer].
Lakartidningen. 1997 Apr 30;94(18):1702, 1707-10.
本文引用的文献
1
Phase II study of PALA, amsacrine, teniposide, and zinostatin in small cell lung carcinoma (EST 2579).
Cancer Treat Rep. 1984 Sep;68(9):1183-4.
2
Treatment of malignant melanoma with camptothecin (NSC-100880).
Cancer Chemother Rep. 1972 Feb;56(1):103-5.
3
Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA.
Proc Natl Acad Sci U S A. 1988 Feb;85(4):1028-32. doi: 10.1073/pnas.85.4.1028.
4
myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course.
J Clin Invest. 1987 Jun;79(6):1629-34. doi: 10.1172/JCI112999.
5
Teniposide in the treatment of non-small cell lung carcinoma.
Cancer Treat Rep. 1987 Jan;71(1):83-5.
6
New drugs in small-cell lung cancer.
Cancer Treat Rev. 1986 Sep;13(3):157-76. doi: 10.1016/0305-7372(86)90003-4.
7
Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial.
Cancer Treat Rep. 1986 Jul;70(7):919-20.
8
Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.
J Clin Oncol. 1986 Apr;4(4):524-7. doi: 10.1200/JCO.1986.4.4.524.
9
Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer.
Nature. 1985;316(6031):823-6. doi: 10.1038/316823a0.
10
Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer.
Cancer Treat Rep. 1985 Jan;69(1):43-6.
Zotero 插件